Suggesting a potential applicability of these findings in the fight against cancer, AKT inhibition attenuates clonogenicity effects of human breast cancer-derived cells in vitro [47] and tumorigenicity from nasopharyngeal cancer cells upon xenotransplantation in vivo [48]. The gene discussed is AKT1; the disease is cancer.